Page last updated: 2024-11-05

sodium pyrophosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Sodium pyrophosphate (Na4P2O7) is an inorganic compound that is a white solid at room temperature. It is a common ingredient in food products as a food additive. It is used as a sequestering agent, emulsifier, and acidity regulator. Sodium pyrophosphate is also used in a variety of industrial applications, including detergents, water treatment, and metal processing. It is produced commercially by heating monobasic sodium phosphate (NaH2PO4) to a temperature of approximately 250 °C. Sodium pyrophosphate is a versatile compound that has a wide range of applications in various industries.'

sodium pyrophosphate: RN refers to diphosphoric acid, tetra-Na salt; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

sodium diphosphate : An inorganic sodium salt comprised of a diphosphate(4-) anion and four sodium(1+) cations. More commonly known as tetrasodium pyrophosphate, it finds much use in the food industry as an emulsifier and in dental hygiene as a calcium-chelating salt. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID24403
CHEBI ID71240
MeSH IDM0044345

Synonyms (78)

Synonym
nsc-56751
sodium phosphate (na4p2o7)
anhydrous tetrasodium pyrophosphate
tetrasodium pyrophosphate
victor tspp
phosphotex
tetrasodium pyrophosphate, anhydrous
sodium pyrophosphate (na4p2o7)
na4p2o7
diphosphoric acid, tetrasodium salt
sodium diphosphate (na4p2o7)
tetrasodium diphosphate
tspp
pyrophosphoric acid tetrasodium salt
sodium pyrophosphate, tetrabasic
tetranatriumpyrophosphat [german]
nsc 56751
hsdb 854
natrium pyrophosphat [german]
einecs 231-767-1
epa pesticide chemical code 076405
caswell no. 847
sodium diphosphate, anhydrous
tetrasodium pyrophosphate, anhydride
sodium pyrophosphate [usan]
sodium pyrophosphate
7722-88-5
D05873
sodium pyrophosphate (usan)
chebi:71240 ,
sodium pyrophosphate(v)
ec 231-767-1
o352864b8z ,
diphosphoric acid, sodium salt (1:4)
natrium pyrophosphat
unii-o352864b8z
tox21_110033
cas-7722-88-5
NCGC00013687-01
dtxcid7022465
dtxsid9042465 ,
FT-0689073
sodium diphosphate
sodium diphosphate tetrabasic
sodium pyrophosphate tetrabasic
sodium pyrophosphate [vandf]
sodium pyrophosphate [hsdb]
sodium pyrophosphate [fcc]
sodium pyrophosphate [ii]
sodium pyrophosphate [mart.]
tetrasodium pyrophosphate [mi]
sodium pyrophosphate [who-dd]
tetrasodium pyrophosphate [inci]
AKOS015914004
FQENQNTWSFEDLI-UHFFFAOYSA-J
tetra sodium pyrophosphate
tetrasodium pyrophosphate anhydrous
AKOS024418778
CS-B1771
diphosphoric acid sodium salt
mfcd00003513
tetrasodium pyrophosphate (anhydrous)
Q418504
E75941
1004291-85-3
sodiumpyrophosphate
tetrasodium (phosphonooxy)phosphonate
EN300-332889
sodium diphosphate (na4(p2o7))
na4o7p2
tetrasodium pyrophosphate (na4p2o7)
dtxcid408842
accoline 126
e 450
sodium pyrophosphate (mart.)
tetron (dispersant)
sodium pyrophosphate (ii)
tetrasodium diphosphate (na4p2o7)

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Therefore, the aim of this study was to investigate Fe bioavailability from bouillon cubes fortified with either FePP only, FePP+NaPP, ferrous sulphate (FeSO4) only, or FeSO4+NaPP."( Sodium pyrophosphate enhances iron bioavailability from bouillon cubes fortified with ferric pyrophosphate.
Cercamondi, CI; Duchateau, GS; Harika, RK; Koppenol, WP; Moretti, D; Murray, P; van den Berg, R; Zeder, C; Zimmermann, MB, 2016
)
1.88
"It is challenging to find an iron compound that combines good bioavailability with minimal sensory changes when added to seasonings or condiments."( High Bioavailability from Ferric Pyrophosphate-Fortified Bouillon Cubes in Meals is Not Increased by Sodium Pyrophosphate: a Stable Iron Isotope Study in Young Nigerian Women.
Blonk, C; Duchateau, GS; Eilander, A; Funke, OM; Moretti, D; Murray, P; Owojuyigbe, TO; Zimmermann, MB, 2019
)
0.73
"We assessed whether there is a dose-response effect of added NaPP on iron bioavailability from local meals prepared with intrinsically labeled FePP-fortified bouillon cubes in young Nigerian women using iron stable isotope techniques."( High Bioavailability from Ferric Pyrophosphate-Fortified Bouillon Cubes in Meals is Not Increased by Sodium Pyrophosphate: a Stable Iron Isotope Study in Young Nigerian Women.
Blonk, C; Duchateau, GS; Eilander, A; Funke, OM; Moretti, D; Murray, P; Owojuyigbe, TO; Zimmermann, MB, 2019
)
0.73
" Iron bioavailability was assessed by measuring 57Fe incorporation into erythrocytes 16 d after each 5 d NaPP: 57Fe feeding period."( High Bioavailability from Ferric Pyrophosphate-Fortified Bouillon Cubes in Meals is Not Increased by Sodium Pyrophosphate: a Stable Iron Isotope Study in Young Nigerian Women.
Blonk, C; Duchateau, GS; Eilander, A; Funke, OM; Moretti, D; Murray, P; Owojuyigbe, TO; Zimmermann, MB, 2019
)
0.73
" Iron bioavailability was 10."( High Bioavailability from Ferric Pyrophosphate-Fortified Bouillon Cubes in Meals is Not Increased by Sodium Pyrophosphate: a Stable Iron Isotope Study in Young Nigerian Women.
Blonk, C; Duchateau, GS; Eilander, A; Funke, OM; Moretti, D; Murray, P; Owojuyigbe, TO; Zimmermann, MB, 2019
)
0.73
"In this study, the addition of NaPP did not increase iron bioavailability from FePP-fortified bouillon cubes."( High Bioavailability from Ferric Pyrophosphate-Fortified Bouillon Cubes in Meals is Not Increased by Sodium Pyrophosphate: a Stable Iron Isotope Study in Young Nigerian Women.
Blonk, C; Duchateau, GS; Eilander, A; Funke, OM; Moretti, D; Murray, P; Owojuyigbe, TO; Zimmermann, MB, 2019
)
0.73
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
"During development of a ranitidine effervescent oral solution dosage form, a marked decrease was observed in the extent of ranitidine absorption relative to the conventional oral tablet."( Effect of sodium acid pyrophosphate on ranitidine bioavailability and gastrointestinal transit time.
Digenis, GA; Donn, KH; Koch, KM; Parr, AF; Powell, JR; Sandefer, EP; Tomlinson, JJ, 1993
)
0.29
" A dose-response effect on total aortic calcification was also documented, with a full inhibition seen at the highest dose."( Daily peritoneal administration of sodium pyrophosphate in a dialysis solution prevents the development of vascular calcification in a mouse model of uraemia.
Barreto, FC; Cook, CS; Drueke, TB; Gass, JH; Holmes, CJ; Louvet, L; Maizel, J; Massy, ZA; Rezg, R; Riser, BL; Valaitis, PW; White, JA, 2011
)
0.65
"We assessed whether there is a dose-response effect of added NaPP on iron bioavailability from local meals prepared with intrinsically labeled FePP-fortified bouillon cubes in young Nigerian women using iron stable isotope techniques."( High Bioavailability from Ferric Pyrophosphate-Fortified Bouillon Cubes in Meals is Not Increased by Sodium Pyrophosphate: a Stable Iron Isotope Study in Young Nigerian Women.
Blonk, C; Duchateau, GS; Eilander, A; Funke, OM; Moretti, D; Murray, P; Owojuyigbe, TO; Zimmermann, MB, 2019
)
0.73
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (84 Items)

ItemProcessFrequency
Seafoodcore-ingredient38
Canned foodscore-ingredient31
Fishescore-ingredient29
Canned tunascore-ingredient28
Tunascore-ingredient28
Canned fishescore-ingredient28
Fatty fishescore-ingredient28
Snackscore-ingredient21
Sweet snackscore-ingredient18
Biscuits and cakescore-ingredient17
Frozen foodscore-ingredient13
Biscuitscore-ingredient11
Cooking helperscore-ingredient10
Meatscore-ingredient9
Meats and their productscore-ingredient9
Fishes and their productscore-ingredient8
Dessert mixescore-ingredient7
Baking Mixescore-ingredient7
Pastry helperscore-ingredient7
Cakescore-ingredient7
Cake mixescore-ingredient7
Prepared meatscore-ingredient5
Sausagescore-ingredient5
Mealscore-ingredient5
Sodascore-ingredient2
Frozen meatscore-ingredient2
Beveragescore-ingredient2
Carbonated drinkscore-ingredient2
Plant-based foodscore-ingredient2
Plant-based foods and beveragescore-ingredient2
Soupscore-ingredient2
Caramel stuffed waferscore-ingredient2
Stuffed waferscore-ingredient2
Waferscore-ingredient2
Biscuits et gâteauxcore-ingredient2
sucréscore-ingredient2
Chocolate biscuitscore-ingredient2
Assortments of biscuitscore-ingredient1
Wheat flatbreadscore-ingredient1
Wheat breadscore-ingredient1
White breadscore-ingredient1
Flatbreadscore-ingredient1
Breadscore-ingredient1
Cereals and potatoescore-ingredient1
Sweetened beveragescore-ingredient1
Lemonadecore-ingredient1
Tuna in brinecore-ingredient1
Canned soupscore-ingredient1
Canned mealscore-ingredient1
Non-alcoholic beveragescore-ingredient1
Sushiscore-ingredient1
Sushis-and-makiscore-ingredient1
Stewscore-ingredient1
Salted snackscore-ingredient1
Pancake mixescore-ingredient1
en:potato-crispscore-ingredient1
Crispscore-ingredient1
Hotpotscore-ingredient1
Sugar-free chewing gumcore-ingredient1
Chewing gumcore-ingredient1
Confectioneriescore-ingredient1
Frozen vegetablescore-ingredient1
Frozen plant-based foodscore-ingredient1
Chips and friescore-ingredient1
Fruits and vegetables based foodscore-ingredient1
Chocolate dessertscore-ingredient1
Dessertscore-ingredient1
en:dried fishcore-ingredient1
Frozen seafoodcore-ingredient1
en:instant-noodlescore-ingredient1
Gâteau moelleux au chocolatcore-ingredient1
Cacao et dérivéscore-ingredient1
Gâteauxcore-ingredient1
Vegetables based foodscore-ingredient1
Appetizerscore-ingredient1
Salty snackscore-ingredient1
Biscuit with a chocolate bar coveringcore-ingredient1
Petit-Beurrecore-ingredient1
Pork sausagescore-ingredient1
Fish fingerscore-ingredient1
Breaded fishcore-ingredient1
Breaded productscore-ingredient1
Fish preparationscore-ingredient1
Canned meatscore-ingredient1

Roles (3)

RoleDescription
food emulsifierA food additive used to form or maintain a uniform emulsion of two (or more) phases in a food.
chelatorA ligand with two or more separate binding sites that can bind to a single metallic central atom, forming a chelate.
food thickening agentA food additive that is used to increase the viscosity of foodstuffs.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
inorganic sodium salt
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (19)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
TDP1 proteinHomo sapiens (human)Potency22.40930.000811.382244.6684AID686978; AID686979
cytochrome P450 family 3 subfamily A polypeptide 4Homo sapiens (human)Potency25.11890.01237.983543.2770AID1346984
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency13.74050.000214.376460.0339AID720691; AID720692
estrogen nuclear receptor alphaHomo sapiens (human)Potency21.70520.000229.305416,493.5996AID743075; AID743079
aryl hydrocarbon receptorHomo sapiens (human)Potency23.31740.000723.06741,258.9301AID743085; AID743122
potassium voltage-gated channel subfamily H member 2 isoform dHomo sapiens (human)Potency35.48130.01789.637444.6684AID588834
Cellular tumor antigen p53Homo sapiens (human)Potency33.49150.002319.595674.0614AID651631
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Carbonic anhydrase Astrosclera willeyanaKi57,700.00000.03201.51729.6000AID647373
Butyrophilin subfamily 3 member A1Homo sapiens (human)IC50 (µMol)1,140.00004.56007.10009.6400AID1569596
Carbonic anhydrase 1Homo sapiens (human)Ki25,770.00000.00001.372610.0000AID1161930; AID416958; AID552781; AID598726; AID647371; AID714401; AID730754; AID763569
Carbonic anhydrase 2Homo sapiens (human)Ki48,500.00000.00000.72369.9200AID1058395; AID1070020; AID1161931; AID1161950; AID1235241; AID1237475; AID1336557; AID1430526; AID1461934; AID416959; AID552782; AID598728; AID647372; AID714400; AID730373; AID730753; AID758952
Carbonic anhydrase 4Homo sapiens (human)Ki1,010.00000.00021.97209.9200AID416960
Mu-type opioid receptorRattus norvegicus (Norway rat)Ki48,500.00000.00000.38458.6000AID1161931
Carbonic anhydrase 7Homo sapiens (human)Ki870.00000.00021.37379.9000AID416961
Carbonic anhydrase 13Mus musculus (house mouse)Ki730.00000.00021.39749.9000AID416962
Carbonic anhydrase Pseudomonas aeruginosa PAO1Ki8,200.00000.07596.26909.0000AID1237477
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Carbonic anhydrase 12Homo sapiens (human)Kinact63,900.00000.00300.66749.6000AID465235
Carbonic anhydrase 9Homo sapiens (human)Kinact46,300.00000.00500.31976.6700AID465234
Carbonic anhydrase 14Homo sapiens (human)Kinact760.00000.00021.44958.5900AID465236
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (148)

Processvia Protein(s)Taxonomy
positive regulation of cytokine productionButyrophilin subfamily 3 member A1Homo sapiens (human)
adaptive immune responseButyrophilin subfamily 3 member A1Homo sapiens (human)
positive regulation of type II interferon productionButyrophilin subfamily 3 member A1Homo sapiens (human)
activated T cell proliferationButyrophilin subfamily 3 member A1Homo sapiens (human)
T cell receptor signaling pathwayButyrophilin subfamily 3 member A1Homo sapiens (human)
regulation of cytokine productionButyrophilin subfamily 3 member A1Homo sapiens (human)
estrous cycleCarbonic anhydrase 12Homo sapiens (human)
chloride ion homeostasisCarbonic anhydrase 12Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 12Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 1Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 2Homo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 2Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 2Homo sapiens (human)
angiotensin-activated signaling pathwayCarbonic anhydrase 2Homo sapiens (human)
regulation of monoatomic anion transportCarbonic anhydrase 2Homo sapiens (human)
secretionCarbonic anhydrase 2Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 2Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 2Homo sapiens (human)
positive regulation of dipeptide transmembrane transportCarbonic anhydrase 2Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 2Homo sapiens (human)
carbon dioxide transportCarbonic anhydrase 2Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 2Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
bicarbonate transportCarbonic anhydrase 4Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 4Homo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 7Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 7Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 7Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 7Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 7Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 7Homo sapiens (human)
response to hypoxiaCarbonic anhydrase 9Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 9Homo sapiens (human)
response to xenobiotic stimulusCarbonic anhydrase 9Homo sapiens (human)
response to testosteroneCarbonic anhydrase 9Homo sapiens (human)
secretionCarbonic anhydrase 9Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 9Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 14Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (39)

Processvia Protein(s)Taxonomy
protein bindingButyrophilin subfamily 3 member A1Homo sapiens (human)
signaling receptor bindingButyrophilin subfamily 3 member A1Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 12Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 12Homo sapiens (human)
arylesterase activityCarbonic anhydrase 1Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 1Homo sapiens (human)
protein bindingCarbonic anhydrase 1Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 1Homo sapiens (human)
hydro-lyase activityCarbonic anhydrase 1Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 1Homo sapiens (human)
arylesterase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 2Homo sapiens (human)
protein bindingCarbonic anhydrase 2Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 2Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 2Homo sapiens (human)
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCarbonic anhydrase 4Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 4Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 4Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 7Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 7Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 9Homo sapiens (human)
protein bindingCarbonic anhydrase 9Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 9Homo sapiens (human)
molecular function activator activityCarbonic anhydrase 9Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 14Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 14Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (37)

Processvia Protein(s)Taxonomy
plasma membraneButyrophilin subfamily 3 member A1Homo sapiens (human)
external side of plasma membraneButyrophilin subfamily 3 member A1Homo sapiens (human)
plasma membraneCarbonic anhydrase 12Homo sapiens (human)
membraneCarbonic anhydrase 12Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 12Homo sapiens (human)
apical plasma membraneCarbonic anhydrase 12Homo sapiens (human)
plasma membraneCarbonic anhydrase 12Homo sapiens (human)
cytosolCarbonic anhydrase 1Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 1Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
cytosolCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
myelin sheathCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 2Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 4Homo sapiens (human)
rough endoplasmic reticulumCarbonic anhydrase 4Homo sapiens (human)
endoplasmic reticulum-Golgi intermediate compartmentCarbonic anhydrase 4Homo sapiens (human)
Golgi apparatusCarbonic anhydrase 4Homo sapiens (human)
trans-Golgi networkCarbonic anhydrase 4Homo sapiens (human)
plasma membraneCarbonic anhydrase 4Homo sapiens (human)
external side of plasma membraneCarbonic anhydrase 4Homo sapiens (human)
cell surfaceCarbonic anhydrase 4Homo sapiens (human)
membraneCarbonic anhydrase 4Homo sapiens (human)
apical plasma membraneCarbonic anhydrase 4Homo sapiens (human)
transport vesicle membraneCarbonic anhydrase 4Homo sapiens (human)
secretory granule membraneCarbonic anhydrase 4Homo sapiens (human)
brush border membraneCarbonic anhydrase 4Homo sapiens (human)
perinuclear region of cytoplasmCarbonic anhydrase 4Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 4Homo sapiens (human)
plasma membraneCarbonic anhydrase 4Homo sapiens (human)
cytosolCarbonic anhydrase 7Homo sapiens (human)
cytoplasmCarbonic anhydrase 7Homo sapiens (human)
nucleolusCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
membraneCarbonic anhydrase 9Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 9Homo sapiens (human)
microvillus membraneCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 14Homo sapiens (human)
membraneCarbonic anhydrase 14Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 14Homo sapiens (human)
apical plasma membraneCarbonic anhydrase 14Homo sapiens (human)
plasma membraneCarbonic anhydrase 14Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (75)

Assay IDTitleYearJournalArticle
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1161950Inhibition of human carbonic anhydrase 2 preincubated for 15 mins by stopped flow CO2 hydration method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Anion inhibition study of the β-class carbonic anhydrase (PgiCAb) from the oral pathogen Porphyromonas gingivalis.
AID598726Inhibition of recombinant human carbonic anhydrase 1 after 15 mins by stopped flow CO2 hydration assay at pH 8.32011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
Inhibition studies with anions and small molecules of two novel β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium.
AID730752Inhibition of Helicobacter pylori alpha carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
Anion inhibition studies of the α-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.
AID730751Inhibition of Vibrio cholerae alpha carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
Anion inhibition studies of the α-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.
AID1161952Inhibition of Porphyromonas gingivalis beta-carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Anion inhibition study of the β-class carbonic anhydrase (PgiCAb) from the oral pathogen Porphyromonas gingivalis.
AID465236Inhibition of human recombinant CA14 by stopped flow CO2 hydration assay2010Bioorganic & medicinal chemistry letters, Mar-01, Volume: 20, Issue:5
Carbonic anhydrase inhibitors. Inhibition of transmembrane isoforms IX, XII, and XIV with less investigated anions including trithiocarbonate and dithiocarbamate.
AID1235242Inhibition of archaeon Methanosarcina thermophila gamma-CA after 15 mins by stopped-flow/Co2 hydration assay2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Cloning, characterization and anion inhibition studies of a new γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis.
AID1569591Activation of BTN3A1 in human PBMC-derived Vgamma9/Vdelta2 T cells assessed as induction of IL2-stimulated IFNgamma production measured after 48 hrs by ELISA2019Journal of medicinal chemistry, 07-25, Volume: 62, Issue:14
Probing the Ligand-Binding Pocket of BTN3A1.
AID1430527Inhibition of Burkholderia pseudomallei recombinant carbonic anhydrase gamma incubated for 15 mins prior to testing by stopped flow CO2 hydration method
AID763567Inhibition of Brucella suis beta carbonic anhydrase-1 at 20 degC by stopped-flow CO2 hydrase assay2013Bioorganic & medicinal chemistry, Aug-01, Volume: 21, Issue:15
Anion inhibition studies of the α-carbonic anhydrase from the protozoan pathogen Trypanosoma cruzi, the causative agent of Chagas disease.
AID416958Inhibition of human recombinant carbonic anhydrase 1-catalyzed CO2 hydration by stopped flow assay2009Bioorganic & medicinal chemistry letters, Apr-01, Volume: 19, Issue:7
Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I, II, III, VII and XIII with less investigated inorganic anions.
AID730372Inhibition of Flaveria bidentis beta-carbonic anhydrase-1 preincubated for 15 mins by stopped flow CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
Kinetic and anion inhibition studies of a β-carbonic anhydrase (FbiCA 1) from the C4 plant Flaveria bidentis.
AID647373Inhibition of Astrosclera willeyana recombinant GST-tagged astrosclerin 3 expressed in Escherichia coli BL21-DE3-RIPL cells preincubated for 15 mins measured for 10 to 100 secs by stopped flow CO2 hydration assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
Anion inhibition studies of an α-carbonic anhydrase from the living fossil Astrosclera willeyana.
AID730753Inhibition of human carbonic anhydrase 2 preincubated for 15 mins by stopped flow CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
Anion inhibition studies of the α-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.
AID677271Inhibition of Helicobacter pylori alpha-carbonic anhydrase-catalyzed CO2 hydration reaction preincubated for 15 mins by stopped flow CO2 hydrase assay2012Bioorganic & medicinal chemistry letters, Sep-01, Volume: 22, Issue:17
Anion inhibition studies of an α-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1.
AID1237477Inhibition of Pseudomonas aeruginosa PAO1 type-2 beta-carbonic anhydrase psCA3 expressed in Escherichia coli Tuner BL21 (DE3) cells pre-incubated for 15 mins at pH 8.3 and 293K by CO2 hydration reaction based colorimetric stopped-flow method2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Structure and inhibition studies of a type II beta-carbonic anhydrase psCA3 from Pseudomonas aeruginosa.
AID416961Inhibition of human recombinant carbonic anhydrase 7-catalyzed CO2 hydration by stopped flow assay2009Bioorganic & medicinal chemistry letters, Apr-01, Volume: 19, Issue:7
Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I, II, III, VII and XIII with less investigated inorganic anions.
AID1161930Inhibition of human carbonic anhydrase 1 preincubated for 15 mins by stopped flow CO2 hydration method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum--the η-carbonic anhydrases.
AID677270Inhibition of Sulfurihydrogenibium yellowstonense YO3AOP1 alpha-carbonic anhydrase-catalyzed CO2 hydration reaction preincubated for 15 mins by stopped flow CO2 hydrase assay2012Bioorganic & medicinal chemistry letters, Sep-01, Volume: 22, Issue:17
Anion inhibition studies of an α-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1.
AID1070022Inhibition of Legionella pneumophila carbonic anhydrase 1 preincubated for 15 mins by stopped-flow CO2 hydrase assay2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Anion inhibition studies of two new β-carbonic anhydrases from the bacterial pathogen Legionella pneumophila.
AID1070021Inhibition of Legionella pneumophila carbonic anhydrase 2 preincubated for 15 mins by stopped-flow CO2 hydrase assay2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Anion inhibition studies of two new β-carbonic anhydrases from the bacterial pathogen Legionella pneumophila.
AID416960Inhibition of human recombinant carbonic anhydrase 4-catalyzed CO2 hydration by stopped flow assay2009Bioorganic & medicinal chemistry letters, Apr-01, Volume: 19, Issue:7
Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I, II, III, VII and XIII with less investigated inorganic anions.
AID598731Inhibition of Salmonella Typhimurium carbonic anhydrase 1 after 15 mins by stopped flow CO2 hydration assay at pH 8.32011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
Inhibition studies with anions and small molecules of two novel β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium.
AID1070020Inhibition of human carbonic anhydrase 2 by stopped-flow CO2 hydrase assay2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Anion inhibition studies of two new β-carbonic anhydrases from the bacterial pathogen Legionella pneumophila.
AID1235245Inhibition of Pseudoalteromonas haloplanktis gamma-CA after 15 mins by stopped-flow/Co2 hydration assay2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Cloning, characterization and anion inhibition studies of a new γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis.
AID1161951Inhibition of Porphyromonas gingivalis gamma-carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Anion inhibition study of the β-class carbonic anhydrase (PgiCAb) from the oral pathogen Porphyromonas gingivalis.
AID714403Inhibition of Sulfurihydrogenibium azorense alpha-carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay2012Bioorganic & medicinal chemistry letters, Dec-01, Volume: 22, Issue:23
Anion inhibition studies of the fastest carbonic anhydrase (CA) known, the extremo-CA from the bacterium Sulfurihydrogenibium azorense.
AID552781Inhibition of human carbonic anhydrase 1 after 15 mins by stopped flow CO2 hydration assay2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Inhibition of the β-carbonic anhydrase from Streptococcus pneumoniae by inorganic anions and small molecules: Toward innovative drug design of antiinfectives?
AID758948Inhibition of Porphyromonas gingivalis recombinant CA by CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
A highly catalytically active γ-carbonic anhydrase from the pathogenic anaerobe Porphyromonas gingivalis and its inhibition profile with anions and small molecules.
AID714401Inhibition of human cytosolic carbonic anhydrase 1 preincubated for 15 mins by stopped flow CO2 hydration assay2012Bioorganic & medicinal chemistry letters, Dec-01, Volume: 22, Issue:23
Anion inhibition studies of the fastest carbonic anhydrase (CA) known, the extremo-CA from the bacterium Sulfurihydrogenibium azorense.
AID465234Inhibition of human recombinant CA9 by stopped flow CO2 hydration assay2010Bioorganic & medicinal chemistry letters, Mar-01, Volume: 20, Issue:5
Carbonic anhydrase inhibitors. Inhibition of transmembrane isoforms IX, XII, and XIV with less investigated anions including trithiocarbonate and dithiocarbamate.
AID1569584Activation of BTN3A1 in human PBMC-derived Vgamma9/Vdelta2 T cells assessed as induction of IL2-stimulated cell proliferation by measuring increase in CD3+ cells preincubated for 3 days followed by 11 days incubation post compound washout and subsequent I2019Journal of medicinal chemistry, 07-25, Volume: 62, Issue:14
Probing the Ligand-Binding Pocket of BTN3A1.
AID1336561Inhibition of Pseudoalteromonas haloplanktis recombinant carbonic anhydrase gamma assessed as inhibition of CO2 hydration preincubated for 15 mins by Lineweaver-burk plot method
AID1569596Displacement of GDP-BODIPY from C-terminal 6His-tagged BTN3A1 B30.2 domain (unknown origin) expressed in Escherichia coli BL21 (DE) measured after 60 mins by fluorescence polarization assay2019Journal of medicinal chemistry, 07-25, Volume: 62, Issue:14
Probing the Ligand-Binding Pocket of BTN3A1.
AID552782Inhibition of human carbonic anhydrase 2 after 15 mins by stopped flow CO2 hydration assay2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Inhibition of the β-carbonic anhydrase from Streptococcus pneumoniae by inorganic anions and small molecules: Toward innovative drug design of antiinfectives?
AID1336557Inhibition of human recombinant carbonic anhydrase 2 assessed as inhibition of CO2 hydration preincubated for 15 mins by Lineweaver-burk plot method
AID1336558Inhibition of Methanosarcina thermophila recombinant carbonic anhydrase gamma assessed as inhibition of CO2 hydration preincubated for 15 mins by Lineweaver-burk plot method
AID647372Inhibition of human recombinant carbonic anhydrase 2 by stopped flow CO2 hydration assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
Anion inhibition studies of an α-carbonic anhydrase from the living fossil Astrosclera willeyana.
AID1058395Inhibition of human cytosolic carbonic anhydrase 2 preincubated for 15 mins by stopped flow CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
Anion inhibition studies of a β-carbonic anhydrase from Clostridium perfringens.
AID714400Inhibition of human cytosolic carbonic anhydrase 2 preincubated for 15 mins by stopped flow CO2 hydration assay2012Bioorganic & medicinal chemistry letters, Dec-01, Volume: 22, Issue:23
Anion inhibition studies of the fastest carbonic anhydrase (CA) known, the extremo-CA from the bacterium Sulfurihydrogenibium azorense.
AID763565Inhibition of recombinant Trypanosoma cruzi CL Brener alpha carbonic anhydrase expressed in baculovirus infected SF9 cells at 20 degC preincubated for 15 mins by stopped-flow CO2 hydrase assay2013Bioorganic & medicinal chemistry, Aug-01, Volume: 21, Issue:15
Anion inhibition studies of the α-carbonic anhydrase from the protozoan pathogen Trypanosoma cruzi, the causative agent of Chagas disease.
AID552785Inhibition of Streptococcus pneumoniae beta-carbonic anhydrase after 15 mins by stopped flow CO2 hydration assay2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Inhibition of the β-carbonic anhydrase from Streptococcus pneumoniae by inorganic anions and small molecules: Toward innovative drug design of antiinfectives?
AID1336562Inhibition of Burkholderia pseudomallei recombinant His-tagged carbonic anhydrase gamma expressed in Escherichia coli BL21 (DE3) assessed as inhibition of CO2 hydration preincubated for 15 mins by Lineweaver-burk plot method
AID1336559Inhibition of Porphyromonas gingivalis recombinant carbonic anhydrase gamma assessed as inhibition of CO2 hydration preincubated for 15 mins by Lineweaver-burk plot method
AID1235244Inhibition of Nostoc commune CA after 15 mins by stopped-flow/Co2 hydration assay2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Cloning, characterization and anion inhibition studies of a new γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis.
AID1237475Inhibition of human carbonic anhydrase-2 by CO2 hydration reaction based colorimetric stopped-flow method2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Structure and inhibition studies of a type II beta-carbonic anhydrase psCA3 from Pseudomonas aeruginosa.
AID647371Inhibition of human recombinant carbonic anhydrase 1 by stopped flow CO2 hydration assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
Anion inhibition studies of an α-carbonic anhydrase from the living fossil Astrosclera willeyana.
AID1430528Inhibition of Burkholderia pseudomallei recombinant His-tagged carbonic anhydrase beta (256 residues) expressed in Escherichia coli BL21 (DE3) incubated for 15 mins prior to testing by stopped flow CO2 hydration method
AID758952Inhibition of human recombinant CA2 by CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
A highly catalytically active γ-carbonic anhydrase from the pathogenic anaerobe Porphyromonas gingivalis and its inhibition profile with anions and small molecules.
AID730373Inhibition of human cytosolic carbonic anhydrase-2 preincubated for 15 mins by stopped flow CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
Kinetic and anion inhibition studies of a β-carbonic anhydrase (FbiCA 1) from the C4 plant Flaveria bidentis.
AID1235243Inhibition of Porphyromonas gingivalis CA after 15 mins by stopped-flow/Co2 hydration assay2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Cloning, characterization and anion inhibition studies of a new γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis.
AID1461938Inhibition of recombinant His6-tagged Francisella tularensis beta-CA (227 residues) expressed in Escherichia coli BL21(DE3) incubated for 15 mins by stopped-flow CO2 hydration assay
AID1336560Inhibition of Nostoc commune recombinant carbonic anhydrase gamma assessed as inhibition of CO2 hydration preincubated for 15 mins by Lineweaver-burk plot method
AID730754Inhibition of human carbonic anhydrase 1 preincubated for 15 mins by stopped flow CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
Anion inhibition studies of the α-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.
AID1430526Inhibition of recombinant human carbonic anhydrase 2 assessed as inhibition of CO2 hydration incubated for 15 mins prior to testing by stopped flow CO2 hydration method
AID1312218Inhibition of Plasmodium falciparum full length recombinant His-fused Eta-carbonic anhydrase domain preincubated for 15 mins by stopped-flow CO2 hydrase assay2016Bioorganic & medicinal chemistry, 09-15, Volume: 24, Issue:18
Anion inhibition profiles of the complete domain of the η-carbonic anhydrase from Plasmodium falciparum.
AID598732Inhibition of Salmonella Typhimurium carbonic anhydrase 2 after 15 mins by stopped flow CO2 hydration assay at pH 8.32011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
Inhibition studies with anions and small molecules of two novel β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium.
AID1058389Inhibition of Clostridium perfringens carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
Anion inhibition studies of a β-carbonic anhydrase from Clostridium perfringens.
AID1161931Inhibition of human carbonic anhydrase 2 preincubated for 15 mins by stopped flow CO2 hydration method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum--the η-carbonic anhydrases.
AID763569Inhibition of human carbonic anhydrase-1 at 20 degC preincubated for 15 mins by stopped-flow CO2 hydrase assay2013Bioorganic & medicinal chemistry, Aug-01, Volume: 21, Issue:15
Anion inhibition studies of the α-carbonic anhydrase from the protozoan pathogen Trypanosoma cruzi, the causative agent of Chagas disease.
AID1161932Inhibition of recombinant Plasmodium falciparum eta-carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum--the η-carbonic anhydrases.
AID416959Inhibition of human recombinant carbonic anhydrase 2-catalyzed CO2 hydration by stopped flow assay2009Bioorganic & medicinal chemistry letters, Apr-01, Volume: 19, Issue:7
Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I, II, III, VII and XIII with less investigated inorganic anions.
AID416962Inhibition of mouse recombinant carbonic anhydrase 13-catalyzed CO2 hydration by stopped flow assay2009Bioorganic & medicinal chemistry letters, Apr-01, Volume: 19, Issue:7
Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I, II, III, VII and XIII with less investigated inorganic anions.
AID1235241Inhibition of human CA2 after 15 mins by stopped-flow/Co2 hydration assay2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Cloning, characterization and anion inhibition studies of a new γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis.
AID465235Inhibition of human recombinant CA12 by stopped flow CO2 hydration assay2010Bioorganic & medicinal chemistry letters, Mar-01, Volume: 20, Issue:5
Carbonic anhydrase inhibitors. Inhibition of transmembrane isoforms IX, XII, and XIV with less investigated anions including trithiocarbonate and dithiocarbamate.
AID598728Inhibition of recombinant human carbonic anhydrase 2 after 15 mins by stopped flow CO2 hydration assay at pH 8.32011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
Inhibition studies with anions and small molecules of two novel β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium.
AID1461935Inhibition of Burkholderia pseudomallei beta-CA incubated for 15 mins by stopped-flow CO2 hydration assay
AID758950Inhibition of Methanosarcina thermophila recombinant gamma-CA by CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
A highly catalytically active γ-carbonic anhydrase from the pathogenic anaerobe Porphyromonas gingivalis and its inhibition profile with anions and small molecules.
AID1461934Inhibition of human CA2 incubated for 15 mins by stopped-flow CO2 hydration assay
AID763566Inhibition of Brucella suis beta carbonic anhydrase-2 at 20 degC by stopped-flow CO2 hydrase assay2013Bioorganic & medicinal chemistry, Aug-01, Volume: 21, Issue:15
Anion inhibition studies of the α-carbonic anhydrase from the protozoan pathogen Trypanosoma cruzi, the causative agent of Chagas disease.
AID1269931Inhibition of Colwellia psychrerythraea gamma carbonic anhydrase expressed in Escherichia coli incubated for 15 mins prior to testing by stopped flow CO2 hydration method2016Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
Cloning, characterization and anion inhibition studies of a γ-carbonic anhydrase from the Antarctic bacterium Colwellia psychrerythraea.
AID730368Inhibition of Helicobacter pylori beta-carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
Kinetic and anion inhibition studies of a β-carbonic anhydrase (FbiCA 1) from the C4 plant Flaveria bidentis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (196)

TimeframeStudies, This Drug (%)All Drugs %
pre-199034 (17.35)18.7374
1990's34 (17.35)18.2507
2000's38 (19.39)29.6817
2010's76 (38.78)24.3611
2020's14 (7.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 88.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index88.17 (24.57)
Research Supply Index5.39 (2.92)
Research Growth Index4.78 (4.65)
Search Engine Demand Index158.53 (26.88)
Search Engine Supply Index2.03 (0.95)

This Compound (88.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials17 (8.46%)5.53%
Reviews1 (0.50%)6.00%
Case Studies3 (1.49%)4.05%
Observational0 (0.00%)0.25%
Other180 (89.55%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]